These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9636471)

  • 1. Immunoglobulin class switch of posttransplant panel reactive antibody and the impact on kidney allograft outcome.
    Sumethkul V; Mongkolsuk T; Sujirachato K; Chiewsilp P
    Transplant Proc; 1998 Jun; 30(4):1167. PubMed ID: 9636471
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow cytometric analysis of antidonor-specific antibodies in liver transplant.
    Piazza A; Adorno D; Torlone N; Valeri M; Poggi E; Monaco PI; Pisani F; Tisone G; Casciani CU
    Transplant Proc; 1997 Nov; 29(7):2975-6. PubMed ID: 9365635
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of antidonor blood type antibody for long-term graft acceptance in ABO-incompatible kidney transplantation.
    Hadano T; Ohara T; Aikawa A; Hasegawa A
    Transplant Proc; 2000 Nov; 32(7):1847-9. PubMed ID: 11119966
    [No Abstract]   [Full Text] [Related]  

  • 7. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidonor-HLA antibodies and soluble HLA antigens after kidney transplant.
    Piazza A; Torlone N; Valeri M; Poggi E; Monaco PI; Provenzani L; Tisone G; Adorno D; Casciani CU
    Transplant Proc; 1993 Dec; 25(6):3279-80. PubMed ID: 8266542
    [No Abstract]   [Full Text] [Related]  

  • 9. The development of chronic renal allograft rejection may be predicted early following transplantation.
    O'Malley KJ; Cook DJ; Flechner SM; McCarthy JF; Thorne NA; Boparai N; Mastroianni BA; Papajcik DA; Modlin CS; Goldfarb DA; Novick AG
    Transplant Proc; 1999; 31(1-2):1352-3. PubMed ID: 10083599
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and immunologic characteristics of transplant recipients with recurrent acute rejection episodes.
    Jacobs U; Niese D; Brensing KA; Klein B; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3231-3. PubMed ID: 8962250
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of chronic antibody mediated-rejection: a case report.
    Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
    Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I residue mismatch and renal graft outcome.
    Piazza A; Canossi A; Buonomo O; Di Rocco M; Del Beato T; Torlone N; Felici A; Cortini C; Casciani CU; Adorno D
    Transpl Int; 2000; 13 Suppl 1():S444-8. PubMed ID: 11112050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical significance of donor-specific alloantibodies in liver transplant recipients.
    Rodrigues H; Monteiro F; Massarolo P; Viggiani C; Preuhs G; Panajotopoulos N; Leitão R; Mies S; Raia S; Kalil J
    Transplant Proc; 1999 Nov; 31(7):2986-7. PubMed ID: 10578359
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.
    Everly MJ; Rebellato LM; Haisch CE; Briley KP; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Maldonado AQ; Harland RC; Terasaki PI
    Transplantation; 2014 Mar; 97(5):494-501. PubMed ID: 24487396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
    Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
    Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports.
    Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E
    Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.